期刊文献+

乳腺癌细胞三维培养耐药模型的体外构建 被引量:5

Development of three-dimensional breast cancer cell culture drug resistance model
原文传递
导出
摘要 本研究旨在体外构建乳腺癌三维(3D)培养模型,部分模拟肿瘤细胞在体微环境,以期建立理想的乳腺癌耐药研究模型。将乳腺癌MCF-7细胞与胶原支架材料复合,体外构建乳腺癌3D培养模型。用Carmine和HE染色法观察细胞形态,用CCK-8法检测细胞增殖情况,用活-死细胞染色试剂盒观察细胞活性,检测3D培养和二维(2D)培养条件下细胞对阿霉素、卡铂、5-氟尿嘧啶的药物敏感性,实时定量RT-PCR检测耐药相关基因P-糖蛋白(P-glycoprotein,P-gp)和多药耐药相关蛋白2(mrp2)m RNA表达水平,用Western blot检测P-gp蛋白的表达。结果显示,3D培养组内MCF-7细胞呈聚团生长,细胞增殖及活性良好。和2D培养组相比,3D培养组细胞对化疗药物的敏感性显著降低,P-gp和mrp2 m RNA水平显著升高,P-gp蛋白水平升高至5.3倍。以上结果提示,本研究成功构建了具有耐药表型及功能的乳腺癌3D培养模型。该模型对深入阐明耐药发生相关机制等研究具有重要意义。 The aim of the present study was to develop three-dimensional(3D) culture model, a more pathologically relevant model, of human breast cancer for drug resistance study. MCF-7 cells were embedded within collagen gel to establish 3D culture model. Cellular morphology was observed using Carmine and HE staining. Cell proliferation was evaluated by CCK-8 assay, and cell activity was detected by Live/Dead staining kit. Drug sensitivities of the 3D culture to doxorubicin, carboplatin, 5-fluorouracil were assayed and compared with those of monolayer(2D) culture. In addition, the levels of drug resistance-related genes P-glycoprotein(P-gp), mrp2 m RNA expressions were detected by real time RT-PCR. Expression level of P-gp protein was detected by Western blot. The results showed that MCF-7 cells in 3D culture formed a number of cell aggregates, and most of them displayed good cell viability. The IC50 values of doxorubicin, carboplatin, 5-fluorouracil were all increased significantly in 3D culture compared with those in 2D culture. Moreover, compared with MCF-7 cells in 2D culture, the cells in 3D culture showed increased m RNA levels of P-gp and mrp2, as well as up-regulated protein expression of P-gp. These results suggest that in vitro collagen-embedded culture system of human breast cancer cells represents an improved pathologically relevant 3D microenvironment for breast cancer cells, providing a robust tool to explore the mechanism of drug resistance of cancer cells.
出处 《生理学报》 CAS CSCD 北大核心 2016年第2期179-184,共6页 Acta Physiologica Sinica
基金 supported by the National Natural Science Foundation of China(No.31470952) Natural Science Foundation of Liaoning Province China(No.2014023003)
关键词 MCF-7 3D培养 胶原支架材料 耐药 breast cancer MCF-7 cell line three-dimensional culture drug resistance
  • 相关文献

参考文献18

  • 1Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin 2015; 65(1): 5-29.
  • 2Fulda S, Debatin KM. Extrinsic versus intrinsic apoptosis pathways in anticancer chemtherapy. Oncogene 2006; 25(34):4798-4811.
  • 3Leslie EM, Deeley RG, Cole SP. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. Toxicol Appl Pharmacol 2005; 204(3):216-237.
  • 4Eicher C, Dewerth A, Kirchner B,Warmann SW, Fuchs J, Armeanu-Ebinger S. Development of a drug resistance model for hepatoblastoma. Int J Oncol 2011; 38(2): 447-454.
  • 5Nakasone ES, Askautrud HA, Kees T, Park JH, Plaks V, Ewald AJ, Fein M, Rasch MG, Tan YX, Qiu J, Park J, Sinha P, Bissell MJ, Frengen E, Werb Z,Egeblad M. Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance. Cancer Cell 2012; 21(4): 488-503.
  • 6Hakanson M, Textor M,Chamley M. Engineered 3D environments to elucidate the effect of environmental parameters on drug response in cancer. Integr Biol 2011; 3(1): 31-38.
  • 7Adjei IM, Blanka S. Modulation of the tumor microenvironment for cancer treatment: a biomaterials approach. J Funct Biomater 2015; 6(1): 81-103.
  • 8Oh SA, Lee HY, Lee JH, Kim TH, Jang JH, Kim HW, Wall I. Collagen three-dimensional hydrogel matrix carrying basic fibroblast growth factor for the cultivation of mesenchymal stem cells and osteogenic differentiation. Tissue Eng Part A 2012; 18(9-10): 1087-1100.
  • 9Egawa EY,Kato K,Hiraoka M, Nakaji-Hirabayashi T, Iwata H. Enhanced proliferation of neural stem cells in a collagen hydrogel incorporating engineered epidermal growth factor. Biomaterials 2011; 32(21): 4737^743.
  • 10Ju RJ, Mu LM, Lu WL. Targeting drug delivery systems for circumventing multidrug resistance of cancers. Ther Deliv 2013; 4(6): 667-671.

同被引文献57

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部